Sudip On Pharma: Is Indian Healthcare Sector Near A Multi-Year Growth Leap?

The Indian pharmaceutical sector continues to attract investor attention amid global uncertainties, tariff concerns, and geopolitical tensions. According to Sudip Bandyopadhyay, Market Expert, the pharma and healthcare space remains one of the most resilient sectors in the market. He highlights several growth drivers, including the rise of branded products, expanding opportunities in CDMO businesses, increasing global efforts to diversify supply chains away from China, and strong growth in the domestic healthcare market. Bandyopadhyay believes Indian pharma companies are steadily moving up the value chain and could be on the verge of a significant transformation. Drawing a parallel with the IT sector's growth journey two decades ago, he sees long-term potential emerging across the pharma and healthcare ecosystem.